# FDA 483 - DR. NELSON E. UZQUIANO - September 11, 2020

Source: https://www.keypedia.com/records/483/dr-nelson-e-uzquiano/468a5e58-4a80-4e9d-a1fb-08e37a6ce090

> FDA 483 for DR. NELSON E. UZQUIANO on September 11, 2020. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: DR. NELSON E. UZQUIANO
- Inspection Date: 2020-09-11
- Product Type: drugs
- Office Name: Dallas District Office
- Summary: An FDA inspection of Nelson E. Uzquiano, M.D., a clinical investigator in Houston, TX, revealed a significant failure to personally supervise an investigation. The investigator did not adequately evaluate abnormal subject findings, ensure recommended follow-ups, or report adverse events as required by the investigational plan and protocol. These deficiencies indicate a lack of proper oversight in the conduct of clinical trials.

## Related Officers

- [CSO](https://www.keypedia.com/people/andrea-a-branche/9ffe9b53-7963-49a6-be4e-25e644f1759f)

Company: https://www.keypedia.com/companies/dr-nelson-e-uzquiano/e6f0f106-b83f-4ddf-a3d9-4af3db6c8b94

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9